PRTA stock · TECH stock

PRTA vs TECH

Prothena Corporation plc (PRTA) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.

Prothena Corporation plc (PRTA) is a biotechnology company listed on US.

Bio-Techne Corp (TECH) is a biotechnology company listed on US.

Latest reported PRTA revenue for 2024-12-31 was $135.2M. Net income was -$122.3M. Revenue was up 47.9% from 2023-12-31 to 2024-12-31. PRTA currently screens at market cap $460.2M.

Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.

PRTA currently screens at market cap $460.2M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.

Not investment advice. Open the PRTA and TECH stock pages for the full models.

Not investment advice.

Popular Stock Comparisons